Sumitomo Mitsui Ds Asset Management Company, LTD Seagen Inc. Transaction History

Sumitomo Mitsui Ds Asset Management Company, LTD

$9.15 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$191.51 - $216.16 $10,533 - $11,888	-55 Reduced 0.43%	12,633 $2.68 Million
Q2 2023 Aug 04, 2023	BUY	$187.64 - $206.25 $184,074 - $202,331	981 Added 8.38%	12,688 $2.44 Million
Q4 2022 Jan 26, 2023	SELL	$117.37 - $139.17 $36,032 - $42,725	-307 Reduced 2.56%	11,707 $0
Q3 2022 Oct 19, 2022	BUY	$135.27 - $180.11 $169,222 - $225,317	1,251 Added 11.62%	12,014 $1.64 Million
Q2 2022 Jul 13, 2022	SELL	$108.81 - $179.33 $35,472 - $58,461	-326 Reduced 2.94%	10,763 $1.9 Million
Q1 2022 Apr 19, 2022	SELL	$119.61 - $157.85 $8,851 - $11,680	-74 Reduced 0.66%	11,089 $1.6 Million
Q4 2021 Jan 20, 2022	BUY	$142.57 - $190.86 $515,390 - $689,958	3,615 Added 47.89%	11,163 $1.73 Million
Q3 2021 Oct 15, 2021	SELL	$142.45 - $169.82 $6,980 - $8,321	-49 Reduced 0.64%	7,548 $1.28 Million
Q2 2021 Jul 19, 2021	SELL	$135.08 - $161.1 $6,754 - $8,055	-50 Reduced 0.65%	7,597 $1.2 Million
Q1 2021 May 07, 2021	BUY	$137.51 - $190.8 $24,614 - $34,153	179 Added 2.4%	7,647 $1.06 Million
Q4 2020 Feb 02, 2021	BUY	$164.63 - $211.93 $1.23 Million - $1.58 Million	7,468 New	7,468 $1.31 Million

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.

Account